Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
This report details a rare case of bilateral ovarian seromucinous borderline tumor and clear cell carcinoma associated with colonic endometriosis, with distinct immunohistochemical profiles suggesting independent origins.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reports an unusual single-patient case in which bilateral ovarian seromucinous borderline tumors (SMBTs) and clear cell carcinoma coexisted, along with typical endometriosis and an atypical polypoid endometrial nodular lesion in the sigmoid colon. The authors describe histopathologic and immunohistochemical characterization of the ovarian and colonic components, noting distinct phenotypes (including Napsin A positivity in clear cell carcinoma but not in the SMBT or colon lesion) and no loss of ARID1A expression across SMBT, clear cell tumor, and endometriotic tissue. A major limitation is that this is a case report with only clinical follow-up (the patient was alive at 4 years postoperatively with no recurrence) and cannot establish causality for tumor development pathways. Relevance to endometriosis: the SMBT and clear cell carcinoma were found together with typical endometriosis lesions in both ovaries and with a polypoid endometriosis–type lesion in the colon, supporting the authors’ proposal of separate endometriotic foci colliding within the ovary.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
8,358 characters
· extracted from
pmc-nxml
· 3 sections
· click to expand
Section 1
Section 2
Section 3
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (16)
- Malignant tumors arising in endometriosis via openalex
- MALIGNANT TUMORS ARISING IN ENDOMETRIOSIS via openalex
- Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis via openalex
- Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms via openalex
- Polypoid endometriosis: a clinicopathologic analysis of 24 cases and a review of the literature via openalex
- W2068368161 via openalex
- W2084845277 via openalex
- W2087568644 via openalex
- W2107119137 via openalex
- W2319137430 via openalex
- W2899823360 via openalex
- W2045572304 via openalex
- W1991356855 via openalex
- W1996843953 via openalex
- W2012136454 via openalex
- W1991055728 via openalex
Cited by (5)
- Carcinoma primario de células claras de pared abdominal en cicatriz posquirúrgica 2026
- Primary abdominal wall clear-cell carcinoma in postsurgical scar 2026
- Clear cell carcinoma of the uterine corpus arising in long-standing adenomyosis after menopause: a case report 2026
- Clear cell carcinoma arising in a seromucinous borderline tumor with co-existing endometriosis- Case report of a rare association 2020
- A diagnostic challenge of seromucinous borderline tumor: A case report 2019
Source provenance
- europepmc
- last seen: 2026-11-22T06:15:05.045840+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:15:47.164179+00:00